APA (7th ed.) Citation

AI, M., EM, A., NFG, E., AAK, E., & S, W. (2022). Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the ‎TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 155, 113752. https://doi.org/10.1016/j.biopha.2022.113752

Chicago Style (17th ed.) Citation

AI, Matouk, Awad EM, El-Tahawy NFG, El-Sheikh AAK, and Waz S. "Dihydromyricetin Alleviates Methotrexate-induced Hepatotoxicity via Suppressing the ‎TLR4/NF-κB Pathway and NLRP3 Inflammasome/caspase 1 Axis." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 155 (2022): 113752. https://doi.org/10.1016/j.biopha.2022.113752.

MLA (9th ed.) Citation

AI, Matouk, et al. "Dihydromyricetin Alleviates Methotrexate-induced Hepatotoxicity via Suppressing the ‎TLR4/NF-κB Pathway and NLRP3 Inflammasome/caspase 1 Axis." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 155, 2022, p. 113752, https://doi.org/10.1016/j.biopha.2022.113752.